Diabetic Neuropathy Newswire

Diabetic Neuropathy Newswire

Comprehensive Real-Time News Feed for Diabetic Neuropathy.

Results 1 - 20 of 202 in Diabetic Neuropathy

  1. Photodynamic therapy effective in treating porphyrias but can be severely painful, cause inflammationRead the original story w/Photo

    Friday | Medical News

    ... have already been tested in the treatment of other types of pain, such as the pain experienced in diabetic neuropathy or arthritis,' explains FAU researcher Prof. Dr. Peter Reeh. 'Based on the findings of this study, these should have two benefits ...

    Comment?

  2. A vulnerability to chronic pain and its interrelationship with resistance to analgesiaRead the original story

    Friday | Brain.oxfordjournals.org

    ... with a particular disease or injury go on to develop chronic pain (see Table 1 in ). For example, diabetic neuropathy is a relatively common condition but only a minority of patients report symptoms of pain. As with many areas of chronic ...

    Comment?

  3. Researchers discover why photodynamic therapy for skin cancer can cause painRead the original story w/Photo

    Thursday Jun 23 | PhysOrg Weblog

    ... have already been tested in the treatment of other types of pain, such as the pain experienced in diabetic neuropathy or arthritis,' explains FAU researcher Prof. Dr. Peter Reeh. 'Based on the findings of this study, these should have two benefits ...

    Comment?

  4. An effective but painful treatmentRead the original story w/Photo

    Wednesday Jun 22 | EurekAlert!

    ... have already been tested in the treatment of other types of pain, such as the pain experienced in diabetic neuropathy or arthritis,' explains FAU researcher Prof. Dr. Peter Reeh. 'Based on the findings of this study, these should have two benefits ...

    Comment?

  5. Global Diabetic Neuropathy Therapeutics Pipeline Review 2016 - Research and MarketsRead the original story w/Photo

    Friday Jun 17 | Business Wire

    This report provides comprehensive information on the therapeutic development for Diabetic Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action , route of administration and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Neuropathy and special features on late-stage and discontinued projects.

    Comment?

  6. New study brings fresh hope to sufferers of diabetic neuropathyRead the original story w/Photo

    Friday Jun 17 | Medical News Today

    ... soft tissue on the sole of the feet and foot ulceration. Working with patients in India who suffer with diabetic neuropathy - a type of nerve damage affecting the feet - researchers used ultrasound elastography to measure the soft tissue stiffness ...

    Comment?

  7. Diabetes Week: How Ely man Michael Harber doesn't let Type 1...Read the original story w/Photo

    Sunday Jun 12 | Cambridge Evening News

    ... disease so it can kill you," added Mr Harber. "I kind of like my feet so I would like to keep them [diabetic neuropathy can lead to nerve damage, especially in the feet. In some cases, this can lead to amputation]. I tend to look after myself. A lot ...

    Comment?

  8. BioDelivery Sciences to Present at the William Blair Annual Growth Stock ConferenceRead the original story

    Wednesday Jun 8 | Freshnews

    ... Pharmaceuticals. Also covered will be an update on the development of Clonidine Topical Gel for painful diabetic neuropathy and the buprenorphine 30 day injection for opioid dependence and chronic pain. The presentation will be webcast live and can ...

    Comment?

  9. BioDelivery To Present At The Annual Growth Stock ConferenceRead the original story

    Tuesday Jun 7 | BioSpace

    The presentation, which will be webcast, is scheduled for BDSI will discuss recently announced strategic initiatives supporting BUNAVAILA buccal film and the launch of BELBUCA buccal film by BDSI's commercial partner, Endo Pharmaceuticals. Also covered will be an update on the development of Clonidine Topical Gel for painful diabetic neuropathy and the buprenorphine 30 day injection for opioid dependence and chronic pain.

    Comment?

  10. BioDelivery Announces Presentation Of Data On The Impact Of A State...Read the original story

    Sunday Jun 5 | BioSpace

    ... address serious and debilitating conditions such as breakthrough cancer pain, chronic pain, painful diabetic neuropathy and opioid dependence. BDSI's headquarters is located in Raleigh, North Carolina. BUNAVAILA (buprenorphine and naloxone) buccal ...

    Comment?

  11. Non-Invasive SUDOSCAN Test Contributes To Value-Based HealthcareRead the original story w/Photo

    Monday Jun 6 | PRWeb

    ... efficacy. "The biggest impact that SUDOSCAN can have is to prevent or detect very early on, impending diabetic neuropathy," said Dr. Marie-Laure NA voret, MD, Medical Director of Impeto Medical. SUDOSCAN's simple to read display may engage the ...

    Comment?

  12. 203 stairsteps to the topaRead the original story w/Photo

    Monday Jun 6 | Albany Times Union

    ... may never visit Florida again, and I can't just say, "Hey, I'll do this next time when I'm older and the diabetic neuropathy that's already affecting my feet and ankles will subside in time." I can barely breathe. But I take in the rarified air. ...

    Comment?

  13. Niagen shown to be effective against diabetes complications in miceRead the original story w/Photo

    Wednesday Jun 1 | NutraIngredients

    A new study done on mice suggests that nicotinamide riboside can help restrict the development of insulin resistance and diabetic neuropathy. Nicotinamide riboside, a form of vitamin B3, is being developed by analytical testing firm and ingredient supplier ChromaDex under the brand name Niagen.

    Comment?

  14. BioDelivery Sciences to Present at the Jefferies 2016 Healthcare ConferenceRead the original story

    Thursday Jun 2 | Freshnews

    ... Pharmaceuticals. Also covered will be an update on the development of Clonidine Topical Gel for painful diabetic neuropathy and the buprenorphine 30 day injection for opioid dependence and chronic pain. The presentation will be webcast live and can ...

    Comment?

  15. BioDelivery To Present At The Jefferies 2016 Healthcare ConferenceRead the original story

    Wednesday Jun 1 | BioSpace

    The presentation, which will be webcast, is scheduled for buccal film by BDSI's commercial partner, Endo Pharmaceuticals. Also covered will be an update on the development of Clonidine Topical Gel for painful diabetic neuropathy and the buprenorphine 30 day injection for opioid dependence and chronic pain.

    Comment?

  16. Impeto Medical to be Featured in Upcoming Episode Airing of Innovations TV SeriesRead the original story w/Photo

    May 25, 2016 | PRWeb

    ... plan. "The biggest impact that Sudoscan can have is to prevent, or detect very early on, impending diabetic neuropathy. This complication affects 50 percent of diabetic patients and our screening efforts have been ineffective," said Dr. Marie-Laure ...

    Comment?

  17. How Diabetes Can Affect Your FeetRead the original story w/Photo

    May 24, 2016 | MedicineNet

    ... complications in people who have diabetes. The feet are especially at risk. Two conditions called diabetic neuropathy and peripheral vascular disease can damage the feet (and other areas of the body) in people who have diabetes. Chronically high ...

    Comment?

  18. Global Emerging Markets Announces Initial Investment In Relief Therapeutics SARead the original story

    May 23, 2016 | BioSpace

    ... is an experimental drug ready to enter clinical testing in patients addressing an unmet medical need in diabetic neuropathy ("DN"). Currently, no similar drugs are approved, while the market for DN-related drugs is expected to increase to USD 4.1 ...

    Comment?

  19. Automated PGP9.5 immunofluorescence staining: a valuable tool in the...Read the original story w/Photo

    May 23, 2016 | BioMed Central

    ... the diagnostic performance of LEPs in the assessment of small nerve fiber loss in asymptomatic diabetic neuropathy. From this study, diabetic subjects presenting with distal polyneuropathy were included. In addition, skin biopsies of healthy ...

    Comment?

  20. Pregabalin Pain And Anxiety Drug May Be Linked To Birth DefectsRead the original story

    May 19, 2016 | Scientific Blogging

    A drug commonly used to treat pain, epilepsy, anxiety and other brain health disorders may be associated with an increased risk of major birth defects, according to a study in Neurology . The drug pregabalin is approved by the FDA to treat epilepsy, fibromyalgia and neuropathic pain, such as pain from diabetic neuropathy or pain after shingles or spinal cord injury.

    Comment?